作者
Mika Paavola, Pekka Kannus, Tero AH Järvinen, Teppo LN Järvinen, Lászlo Józsa, Markku Järvinen
发表日期
2002/9/1
来源
Foot and ankle clinics
卷号
7
期号
3
页码范围
501-513
出版商
Elsevier
简介
Hench and co-workers [1] won the Nobel prize for medicine in 1950 for reporting the effects of the steroid hormone on the rheumatoid joint. Hollander et al [2] explained in 1951 how steroids could be used locally with reduction of systemic side effects. Since then, corticosteroid injections have been used widely in the treatment of musculoskeletal conditions, including acute and chronic tendon disorders.
Tendon injuries and other tendon disorders are a source of major concern in competitive and recreational athletes. It is estimated that overuse-type injuries account for 30% to 50% of all sports injuries [3]. High incidence of chronicity and recurrence result in appreciable morbidity and, in patients with work-induced tendon complaints, loss of productivity, representing a major socioeconomic detriment. In many sports events, especially in endurance and power sports,
引用总数
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024631212582411131013915146911471155
学术搜索中的文章
M Paavola, P Kannus, TAH Järvinen, TLN Järvinen… - Foot and ankle clinics, 2002